Mental Health & Behavioral Research, Phase IB

Effects of Repeated Psilocybin Dosing in OCD

Volunteers
Health Professionals

What is the purpose of this trial?

This study aims to investigate the effects of repeated dosing of oral psilocybin on obsessive-compulsive disorder (OCD) symptomatology in a randomized, waitlist-controlled design with blinded independent ratings, and assess psychological mechanisms that may mediate psilocybin's therapeutic effects on OCD.

If interested please email Terence Ching, PhD, at terence.ching@yale.edu or Sarah Shnayder at sarah.shnayder@yale.edu.

Trial with
Cohen Foundation
Ages
18 years - 65 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Terence Ching

terence.ching@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Benjamin Kelmendi, MD
Assistant Professor of Psychiatry

Sub-Investigators

Last Updated
02/02/2024
Study HIC
#2000032623